Showing 1 - 4 results of 4 for search 'Massimo Stefano Luca Bernardi', query time: 0.04s Refine Results
  1. 1
    PB2004: CHRONIC MYELOMONOCYTIC LEUKEMIA AND CONCOMITANT MONOCLONAL GAMMOPATHY: A MULTICENTRE RETROSPECTIVE STUDY OF CLINICAL CHARACTERISTICS, PREVALENCE AND OUTCOME

    PB2004: CHRONIC MYELOMONOCYTIC LEUKEMIA AND CONCOMITANT MONOCLONAL GAMMOPATHY: A MULTICENTRE RETROSPECTIVE STUDY OF CLINICAL CHARACTERISTICS, PREVALENCE AND OUTCOME by Elisa Diral, Gregorio Maria Bergonzi, Elena Elli, Fabrizio Cavalca, Stefano Crippa, Lorenzo Rizzo, Marta Riva, Fabio Ciceri, Massimo Stefano Luca Bernardi

    Published 2023-08-01
    Get full text
    Article
  2. 2
    PB2426: SORAFENIB MAINTENANCE TAILORED TO FLT3-MUTATED AML AFTER ALLOGENEIC HCT IS HIGHLY FEASIBLE AND EFFECTIVE: A REAL-LIFE EXPERIENCE

    PB2426: SORAFENIB MAINTENANCE TAILORED TO FLT3-MUTATED AML AFTER ALLOGENEIC HCT IS HIGHLY FEASIBLE AND EFFECTIVE: A REAL-LIFE EXPERIENCE by Elisa Diral, Giulia Furnari, Francesca Farina, Daniela Clerici, Sarah Marktel, Raffaella Greco, Gloria Catalano, Alessandro Bruno, Edoardo Campodonico, Elisabetta Xue, Sara Mastaglio, Luca Vago, Massimo Stefano Luca Bernardi, Matteo Giovanni Carrabba, Consuelo Corti, Jacopo Peccatori, Fabio Ciceri, Maria Teresa Lupo Stanghellini

    Published 2023-08-01
    Get full text
    Article
  3. 3
    P502: PHASE II STUDY ON VENETOCLAX PLUS DECITABINE FOR ELDERLY (≥60 <75YEARS) PATIENTS WITH NEWLY DIAGNOSED HIGH-INTERMEDIATE RISK AML ELEGIBLE FOR ALLO-SCT: MIDTERM UPDATE OF VEN-DEC GITMO STUDY

    P502: PHASE II STUDY ON VENETOCLAX PLUS DECITABINE FOR ELDERLY (≥60 <75YEARS) PATIENTS WITH NEWLY DIAGNOSED HIGH-INTERMEDIATE RISK AML ELEGIBLE FOR ALLO-SCT: MIDTERM UPDATE OF VEN-... by Domenico Russo, Nicola Polverelli, Marika Vezzoli, Stella Santarone, Luca Castagna, Francesco Onida, Stefania Bramanti, Roberto Sorasio, Angelo Michele Carella, Attilio Olivieri, Calogero Vetro, Germana Beltrami, Antonio Curti, Massimo Stefano Luca Bernardi, Valentina Mancini, Pellegrino Musto, Elisabetta Terruzzi, Piero Galieni, Cristina Skert, Luisa Giaccone, Raffaella Cerretti, Erika Borlenghi, Mirko Farina, Alessandro Leoni, Simona Bernardi, Stefano Calza, Angela Gheorghiu, Michele Malagola, Massimo Martino, Fabio Ciceri

    Published 2023-08-01
    Get full text
    Article
  4. 4
    P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE

    P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE by Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Elisa Galossi, Giulia Falconi, Alessandro Bruno, Francesca Crisafulli, Micol Frassi, Chiara Cattaneo, Diego Bertoli, Massimo Stefano Luca Bernardi, Annalisa Condorelli, Erika Morsia, Elena Crisà, Paola Triggianese, Beatrice Borsellino, Luisa Brussino, Giorgia Battipaglia, Sara Bindoli, Paolo Sfrisio, Federico Caroni, Antonio Curti, Cristina Papayannidis, Attilio Olivieri, Shahram Kordasti, Francesco Albano, Fabrizio Pane, Pellegrino Musto, Monica Bocchia, Elisabetta Lugli, Massimo Breccia, Marco Frigeni, Lorenzo Dagna, Raffaella Greco, Franco Franceschini, Corrado Campochiaro, Luca Cantarini, Maria Teresa Voso

    Published 2023-08-01
    Get full text
    Article

Search Tools: